SCHEMBL8317456

SCHEMBL8317456

FC(F)(F)c1ccc(C(CBr)c2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACP3 P15309 1/20 0.51
TSHR P16473 2/20 0.50
ALDH1A1 P00352 1/20 0.50
KIF11 P52732 1/20 0.48
SLC6A3 Q01959 5/20 0.45
SLC6A4 P31645 4/20 0.45
SLC6A2 P23975 3/20 0.45
CACNA1C Q13936 3/20 0.45
KCNK2 O95069 2/20 0.45
KCNH2 Q12809 2/20 0.45
HSD11B1 P28845 1/20 0.45
CACNA1A O00555 1/20 0.44
CACNA2D1 P54289 1/20 0.44
CACNA1B Q00975 1/20 0.44
CACNB1 Q02641 1/20 0.44
PDPK1 O15530 1/20 0.44
CNR2 P34972 1/20 0.44
SLC7A5 Q01650 3/20 0.42
HRH3 Q9Y5N1 2/20 0.42
NPC1 O15118 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL605443 0.80 HTR2A (0.64) ACP3TSHRALDH1A1KIF11SLC6A3
SCHEMBL7074111 0.80 ACP3 (0.51) ACP3TSHRALDH1A1KIF11SLC6A3
SCHEMBL12086021 0.80 ACP3 (0.51) ACP3TSHRALDH1A1KIF11SLC6A3
SCHEMBL1666064 0.80 HTR2A (0.52) TSHRALDH1A1MTORRAB9AHTR2A
SCHEMBL7523008 0.79 ACP3 (0.55) ACP3TSHRALDH1A1KIF11SLC6A3
SCHEMBL7783843 0.78 HSD11B1 (0.50) ACP3KIF11HSD11B1PDPK1CNR2
SCHEMBL5161949 0.77 HRH1 (0.67) ACP3TSHRALDH1A1SLC6A3SLC6A4
SCHEMBL8233890 0.77 ACP3 (0.47) ACP3TSHRALDH1A1KIF11CACNA1C
SCHEMBL28495393 0.77 TSHR (0.56) ACP3TSHRALDH1A1KIF11SLC6A3
SCHEMBL6703510 0.76 ACP3 (0.51) ACP3TSHRALDH1A1KIF11SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0929534-A1 TRYCYCLIC COMPOUNDS AS PROSTAGLANDIN I2 RECEPTOR AGONISTS Takeda Pharmaceutical Company Limited (JP) 1999-07-21 EP disclosed
WO-1998013356-A1 TRYCYCLIC COMPOUNDS AS PROSTAGLANDIN I2 RECEPTOR AGONISTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-04-02 WO disclosed